Literature DB >> 3398121

Results of surgical treatment of renal cell carcinoma with solitary metastasis.

M K Dineen1, R D Pastore, L J Emrich, R P Huben.   

Abstract

To determine the effect on survival of excision of a solitary metastasis from renal cell carcinoma, the records of 29 patients seen at our institute within the last 15 years (1972 to 1986) who underwent such an operation were reviewed. Metastasis was present at diagnosis in 11 of the 29 patients, while 18 had metastasis 2 months to 11 years after nephrectomy, with an average interval free of disease of 38 months. There were 13 pulmonary metastases, 6 bone lesions and 10 other lesions. The estimated over-all survival rate for this group was 41 per cent at 2 years and 13 per cent at 5 years after excision of the metastasis. Only 2 of the 29 patients currently are alive with no evidence of disease 42 and 53 months since excision of the metastasis. Neither the presence nor absence of a metastasis at diagnosis nor the interval between nephrectomy and the development of a metastasis in patients without metastatic disease at diagnosis appeared to influence survival after excision of the metastasis. Unlike previous reports, these results suggest that the beneficial effects of excision of metastatic renal cell carcinoma are limited to improved short-term survival postoperatively and that surgical cure of patients with metastatic renal cell carcinoma is a relatively uncommon event.

Entities:  

Mesh:

Year:  1988        PMID: 3398121     DOI: 10.1016/s0022-5347(17)41582-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Rationale for immunotherapy of renal cell carcinoma.

Authors:  R Heicappell; R Ackermann
Journal:  Urol Res       Date:  1990

2.  Renal cell carcinoma with solitary synchronous pancreaticoduodenal and metachronous periprostatic metastases: report of a case.

Authors:  I Yavaşçaoğlu; N Korun; B Oktay; U Simşek; M Ozyurt
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

3.  Liver resection for metastases from renal cell carcinoma.

Authors:  Armin Thelen; S Jonas; C Benckert; E Lopez-Hänninen; B Rudolph; U Neumann; P Neuhaus
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

4.  [Results of surgical treatment of metastases of renal carcinomas in 65 operated cases].

Authors:  P Simon; M Katzner; P Montes; P Gleyze; S R Babin
Journal:  Eur J Orthop Surg Traumatol       Date:  1996-02

5.  Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review.

Authors:  P C Kierney; J A van Heerden; J W Segura; A L Weaver
Journal:  Ann Surg Oncol       Date:  1994-07       Impact factor: 5.344

6.  Treatment for liver metastasis from renal cell carcinoma with computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT): a case series.

Authors:  Dominik Geisel; Federico Collettini; Timm Denecke; Christian Grieser; Anne Flörcken; Peter Wust; Bernd Hamm; Bernhard Gebauer
Journal:  World J Urol       Date:  2012-11-07       Impact factor: 4.226

Review 7.  Metastatic renal cell carcinoma presenting as epistaxis.

Authors:  H-M Lee; H J Kang; S H Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-02-19       Impact factor: 2.503

8.  Bone metastases from renal cell carcinoma: patient survival after surgical treatment.

Authors:  Andreas Fottner; Melinda Szalantzy; Lilly Wirthmann; Michael Stähler; Andrea Baur-Melnyk; Volkmar Jansson; Hans Roland Dürr
Journal:  BMC Musculoskelet Disord       Date:  2010-07-03       Impact factor: 2.362

9.  Atypical Metastasis to the Head and Neck Region: An Analysis of 11 Patients.

Authors:  Bayram Şahin; Can Doruk; Mehmet Çelik; Erkan Öztürk; Selçuk Güneş; Ökkeş Erkan Kıyak
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-10-26

10.  Lung metastasectomy following kidney tumors: outcomes and prognostic factors from a single-center experience.

Authors:  Elisa Meacci; Dania Nachira; Maria Teresa Congedo; Venanzio Porziella; Marco Chiappetta; Gianmaria Ferretti; Amedeo Iaffaldano; Leonardo Petracca Ciavarella; Stefano Margaritora
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.